Impact of lyophilized rhBNP combined with furosemide on serum myocardial enzymes in elderly patients with AHF
Yin Jia
Tang Shujie
Abstract：Objective To explore the effect of lyophilized recombinant human brain natriuretic pep-tide(rhBNP)combined with furosemide on serum myocardial enzymes levels in elderly patients with acute heart failure(AHF).Methods A total of 162 elderly AHF patients admitted in our de-partment from January 2020 to November 2023 were recruited,and randomly divided into furose-mide group and furosemide+rhBNP group,with 81 cases in each group.The remission times of clinical symptoms were observed in the two groups.The score of heart failure degree,disease se-verity score,echocardiographic indicators and serum biochemical indicators before and in 2 weeks after treatment were studied and compared between the two groups.These indicators included left ventricular end-systolic diameter(LVESD),left ventricular ejection fraction(LVEF),left ventri-cular end-diastolic diameter(LVEDD),stroke volume(SV),and levels of α-hydroxybutyrate de-hydrogenase(α-HBDH),creatine kinase(CK),creatine kinase isoenzyme(CK-MB),lactate dehy-drogenase(LDH)and micro ribonucleic acid-181b(miR-181b),transient receptor potential C1(TRPC1)and growth differentiation factor 15(GDF-15).Results The remission time of short-ness of breath and time of edema subsidence after treatment were significantly shorter in the furo-semide+rhBNP group than the furosemide group(3.31±0.62 d vs 5.18±1.08 d,3.86±0.82 d vs 6.08±1.19 d,P＜0.01).After treatment,the heart failure degree score,APACHE Ⅱ score,LVEDD,LVESD,and levels of LDH,CK,CK-MB,α-HBDH,TRPC1 and GDF-15 were obviously declined,while LVEF,SV and miR-181b level were notably risen in both groups when compared to the levels before treatment(P＜0.05).Conclusion rhBNP combined with furosemide can shorten the duration of AHF symptoms in the elderly patients.It can not only relieve the disease condition of heart failure,but also improve serum myocardial enzyme indicators,alleviate the my-ocardial injury and protect the heart in the patients.
Keywords：natriuretic peptidelipoprotein(a)furosemideheart failurehydroxybutyrate dehydro-genase
Publication Date：2024-07-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 732-736 )